Contract award · 13 May 2025

Blood Group Genotyping for Sickle Cell and Thalassaemi

NHS England, Leeds awarded “Blood Group Genotyping for Sickle Cell and Thalassaemi” to NHS Blood and Transplant (NHSBT) for £141k on 13 May 2025.

Health & social careYorkshire and the Humber

Value £141k

Procedure

Procedure as published: Other -.

Key facts

Value
£140,671
Procedure
Other -
Sector
Health & social care · Blood analysis services (CPV 85111810)
Timeline
  1. Contract date13 May 2025
  2. Published3 Sep 2025Published 113 days after the contract date

Description

The main output of this programme is for blood group genotyping to become embedded into routine practice. Primary objective (benefit) of doing so is to ensure patients with rare blood disorders have a minimise risk of adverse reactions through access to blood group genotyping.

About the supplier

More from NHS England, Leeds

All contracts

More won by NHS Blood and Transplant (NHSBT)

All contracts

Recent health & social care contracts

Sector overview